Starpharma Holdings Limited (SPHRF)

OTCMKTS · Delayed Price · Currency is USD
0.0982
+0.0142 (16.90%)
At close: Aug 26, 2025
16.90%
Market Cap34.44M
Revenue (ttm)3.84M
Net Income (ttm)-6.55M
Shares Outn/a
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,821
Average Volume13,126
Open0.0982
Previous Close0.0840
Day's Range0.0982 - 0.0982
52-Week Range0.0540 - 0.0982
Beta0.32
RSI54.06
Earnings DateAug 22, 2025

About Starpharma Holdings

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications internationally. The company’s products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It is also involved in the development of a dendrimer-enhanced product (DEP... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 40
Stock Exchange OTCMKTS
Ticker Symbol SPHRF
Full Company Profile

Financial Performance

In 2025, Starpharma Holdings's revenue was 5.85 million, a decrease of -40.04% compared to the previous year's 9.76 million. Losses were -9.99 million, 22.4% more than in 2024.

Financial numbers in AUD Financial Statements

News

There is no news available yet.